image
Healthcare - Biotechnology - NASDAQ - US
$ 30.56
-2.43 %
$ 2.38 B
Market Cap
98.58
P/E
BALANCE SHEET
1.3 B ASSETS
16.60%
124 M LIABILITIES
75.23%
1.18 B EQUITY
12.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Veracyte, Inc.
image
Current Assets 372 M
Cash & Short-Term Investments 289 M
Receivables 46.5 M
Other Current Assets 36.3 M
Non-Current Assets 962 M
Long-Term Investments 0
PP&E 71.1 M
Other Non-Current Assets 891 M
21.70 %3.49 %5.33 %66.76 %Total Assets$1.3b
Current Liabilities 78.6 M
Accounts Payable 8.63 M
Short-Term Debt 7.5 M
Other Current Liabilities 62.5 M
Non-Current Liabilities 45.4 M
Long-Term Debt 43.2 M
Other Non-Current Liabilities 2.2 M
6.96 %6.05 %50.37 %34.85 %Total Liabilities$124.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 239.1 216.5 154.2 173.2 349.4 159.3 78.0 33.9 59.2 39.1 35.0 71.2 14.0 7.6
Short Term Investments 50.4 0 24.6 4.0 0 0 0 0 0 0 0 0 0 0
Receivables 46.5 40.4 44.0 41.5 18.5 19.3 13.2 12.7 8.8 3.5 3.0 1.1 0.6 0.2
Inventory 21.8 16.1 14.3 11.2 4.7 6.8 3.4 5.3 3.5 3.8 3.7 2.6 1.1 0.3
Other Current Assets 14.6 12.7 11.5 17.2 3.2 2.2 2.4 4.0 2.2 1.6 1.6 3.0 0.8 0.5
Total Current Assets 372.3 285.6 248.6 243.1 375.7 187.7 97.0 53.9 73.6 47.9 43.3 76.4 16.4 8.6
PP&E 71.1 30.9 30.9 31.1 16.8 17.7 8.9 9.7 11.5 10.3 4.2 3.0 2.4 1.7
Intangible Assets 102.3 88.6 174.9 202.7 59.9 65.0 12.0 13.1 14.1 15.2 16.0 0.3 0.2 0
Goodwill 745.8 703.0 695.9 707.9 2.7 2.7 1.1 1.1 1.1 1.1 1.1 0 0 0
Long Term Investments 0 0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 (0.3) 0 0 0
Other Long Term Assets 42.5 6.8 (26.8) (35.1) 2.0 2.0 1.7 0.9 0.7 0.8 0.3 16 K 56 K 0.2
Other Assets (34.0) 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 300.0 1 114.9 1 156.4 1 187.8 457.2 275.2 120.6 78.7 101.0 75.3 64.8 79.6 19.1 10.5
LIABILITIES
Accounts Payable 8.6 12.9 11.9 12.4 3.1 2.3 2.5 3.9 2.4 5.1 7.4 5.3 1.9 0.6
Short Term Debt 7.5 5.1 8.1 8.4 3.2 2.8 1.4 0 0 0 0 0 0 0
Other Current Liabilities 60.8 41.2 40.0 38.8 10.1 12.3 9.2 8.2 9.1 9.6 9.7 10.1 7.1 1.3
Total Current Liabilities 78.6 61.2 62.6 64.2 16.8 17.5 13.1 12.0 11.5 14.7 17.1 15.4 9.0 1.9
Long Term Debt 43.2 7.5 10.6 14.1 10.7 12.2 23.9 25.2 25.5 5.0 4.9 4.9 0 0
Deferred Tax Income 1.2 0.7 4.5 5.6 0 0 0 0 0 0 0.3 0 0 0
Other Liabilities 1.0 1.3 3.4 7.1 7.6 6.1 3.9 4.2 4.4 4.3 1.1 2.9 5.2 0
Total Liabilities 124.1 70.8 81.2 91.3 35.9 35.8 40.9 41.4 41.5 24.0 23.5 23.2 14.2 1.9
EQUITY
Common Stock 78 K 73 K 72 K 71 K 58 K 50 K 41 K 34 K 34 K 28 K 23 K 21 K 1 K 1 K
Retained Earnings (444.0) (468.1) (393.7) (357.2) (281.6) (246.7) (234.1) (211.1) (180.1) (148.7) (115.0) 56.4 (60.1) (41.4)
Other Accumulative Comprehensive Income/Loss (36.1) (24.0) (31.3) (15.1) 0 0 (12.0) (9.3) (6.8) (5.4) (4.0) (2.8) (1.8) (1.1)
Total Equity 1 176.0 1 044.1 1 075.2 1 096.5 421.2 239.5 79.8 37.2 59.6 51.3 41.4 56.4 4.9 8.5
Total Liabilities and Equity 1 300.0 1 114.9 1 156.4 1 187.8 457.2 275.2 120.6 78.7 101.0 75.3 64.8 79.6 19.1 10.5
SHARES OUTSTANDING
Common Shares Outstanding 76.5 72.6 71.5 67.9 53.2 46.1 37.0 33.9 28.8 25.9 21.6 4.2 14.2 14.2